All above results demonstrate that USP11 is related to the occurrence and progression of multiple cancers, targeting USP11 or using ono-specific USP11 inhibitor mitoxantrone is a feasible and effective therapeutic approach for various cancer treatment. This evidence concerns the gene USP11 and cancer.